WEALTH EFFECTS LLC

Position in SCYX — Scynexis Inc

CIK 1907254 BOSTON, MA

Position in SCYX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$56,467

-$23,770 QoQ

Shares Held

13,874

+26.8% QoQ

Ownership

0.139%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#23

of 39 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH EFFECTS LLC holds $368,827 across 3 Drug Manufacturers - Specialty & Generic names. SCYX ranks #2 (15.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	5,700	$298,680
2	SCYX	Scynexis Inc This page	13,874	$56,467
3	AKBA	Akebia Therapeutics, Inc.	12,000	$13,680

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$56,467	13,874	-84.1%	Shares	Sole	2026-08-06
2026-03-31	$80,237	87,500	-4.4%	Shares	Sole	2026-04-21
2025-12-31	$57,828	91,500	-8.0%	Shares	Sole	2026-01-26
2025-09-30	$76,615	99,500	0.0%	Shares	Sole	2025-10-28
2025-06-30	$67,162	99,500	+11.2%	Shares	Sole	2025-07-15
2025-03-31	$85,204	89,500	-4.8%	Shares	Sole	2025-04-23
2024-12-31	$113,740	94,000	-7.8%	Shares	Sole	2025-01-22
2024-09-30	$151,980	102,000	-8.5%	Shares	Sole	2024-10-21
2024-06-30	$223,000	111,500	-2.6%	Shares	Sole	2024-08-02
2024-03-31	$168,315	114,500	-2.6%	Shares	Sole	2024-04-22
2023-12-31	$262,025	117,500	+26.3%	Shares	Sole	2024-01-29
2023-09-30	$212,040	93,000	+30.9%	Shares	Sole	2023-10-16
2023-06-30	$209,597	71,050	+16.4%	Shares	Sole	2023-07-18
2023-03-31	$183,150	61,050	-0.8%	Shares	Sole	2023-05-04
2022-12-31	$96,018	61,550	-29.7%	Shares	Sole	2023-02-02
2022-09-30	$210,120	87,550	-2.2%	Shares	Sole	2022-11-14
2022-06-30	$166,563	89,550	-2.7%	Shares	Sole	2022-08-03
2022-03-31	$359,915	92,050	+4.8%	Shares	Sole	2022-05-16
2021-12-31	$535,580	87,800	—	Shares	Sole	2022-02-09
No filing history on record for this holder in this stock.